AIM ImmunoTech, Inc. (AIM) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

NRX Pharmaceuticals, Inc.

Cumberland Pharmaceuticals, Inc.

Regulus Therapeutics, Inc.

Indaptus Therapeutics, Inc.

Context Therapeutics, Inc.

KALA BIO, Inc.

MyMD Pharmaceuticals, Inc.

Genprex, Inc.

AIM ImmunoTech, Inc.

NLS Pharmaceutics Ltd.

AgeX Therapeutics, Inc.

Why is AIM ImmunoTech, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-1.23%

EBIT Growth (5y)

-1.27%

EBIT to Interest (avg)

-20.43

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.02

Sales to Capital Employed (avg)

0.01

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

13.48%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-0.49

EV to EBIT

-0.19

EV to EBITDA

-0.19

EV to Capital Employed

-0.42

EV to Sales

2.66

PEG Ratio

Dividend Yield

4464.49%

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bullish

Bollinger Bands

Bearish

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -11.32 MM

NET PROFIT(HY)

Higher at USD -5.35 MM

RAW MATERIAL COST(Y)

Fallen by -64.83% (YoY

OPERATING PROFIT(Q)

Highest at USD -2.18 MM

EPS(Q)

Highest at USD -0.69

-14What is not working for the Company

NET SALES(HY)

At USD 0.04 MM has Grown at -29.51%

INTEREST(HY)

At USD 0.7 MM has Grown at 171.48%

Here's what is working for AIM ImmunoTech, Inc.

Operating Cash Flow

Highest at USD -11.32 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit

Higher at USD -5.35 MM

than preceding 12 month period ended Mar 2026

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Operating Profit

Highest at USD -2.18 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

EPS

Highest at USD -0.69

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost

Fallen by -64.83% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for AIM ImmunoTech, Inc.

Net Sales

At USD 0.04 MM has Grown at -29.51%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (USD MM)

Interest

At USD 0.7 MM has Grown at 171.48%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)